drugset / Trial / NCT00494013

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

NCT00494013

Phase 3 Completed 442 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effectiveness and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin therapy in adults with type 2 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.

Timeline

Start
2007-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin detemir Protein / enzyme biologic Subcutaneous